Osimertinib-Induced Cardiotoxicity
Objectives: The goal of this study was to compare the risk of cardiotoxicity with osimertinib versus all other drugs and versus epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitors (TKIs) (erlotinib, afatinib, and gefitinib) in the U.S. Food and Drug Administration Adverse Events Repor...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-12-01
|
| Series: | JACC. CardioOncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666087319300833 |